Back to search results
NCT05921487

Time Restricted Eating to Mitigate Obesity in Veterans With Spinal Cord Injury

Enrolling by Invitation
NAAges 18–89Interventional
VA Office of Research and Development
~15 participants
Updated 2026-06-04 on ClinicalTrials.gov
What's tested:Time Restricted Eating

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in the daily eating window
Measured over Measured weekly from baseline to week 6

Conditions

Spinal Cord Injury
Obesity

Explore related trials

ObesitySpinal Cord Injury

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • Geoffrey V Henderson, MD · PRINCIPAL_INVESTIGATOR · Syracuse VA Medical Center, Syracuse, NY

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Veteran, age 18 to 89 years old
The Syracuse SCI registry includes adults only, so the youngest age of enrollment is 18. The effects of fasting on age-induced sarcopenia remain "uncertain"; therefore, the investigators will cap the age at 89 years old
A member of the Spinal Cord Injury/Disorder (SCI/D) registry through the Syracuse VA, including both hub and spoke sites
A qualifying diagnosis of SCI within the SCI/D registry
Neurologic level of injury from T1 to S5, based on most recent Status Update or ASIA examination, or a diagnosis of a hereditary form of paraplegia (such as familial spastic paraplegia or hereditary spastic paraplegia)
ASIA Impairment Scale grade A-D
Chronic SCI (\> 1 year from date of SCI or diagnosis of SCI)
BMI \> 22 - the BMI used to diagnose obesity in individuals with SCI
Mean eating window of at least 10 hours per day

Exclusion

Females who are pregnant (tested via urinary hCG), planning to become pregnant in the next 6 months, or breast-feeding
A member of the SCI/D registry through the Syracuse VA, with a qualifying diagnosis of MS or ALS
Diagnosis of heart failure
Diagnosis of diabetes mellitus, type 1
Diagnosis of diabetes mellitus, type 2, and on insulin or other antidiabetic agent with high incidence of hypoglycemia
Diagnosis of End Stage Renal Disease
Diagnosis of dementia
Diagnosis of orthostatic hypotension and prescribed midodrine or fludrocortisone
History of syncopal episode in the month prior to the study
History of significant weight loss (\> 10% body weight) in the month prior to the study
History of eating disorders (e.g., anorexia or bulimia) within the last five years, or clearance from a mental health provider
History of active suicidal ideation in the last six months, or clearance from a mental health provider
Currently prescribed weight loss medication (e.g., liraglutide)
Currently prescribed corticosteroids
Current acute medical issues including cancer, sepsis, advanced liver failure, porphyria, or uncontrolled hyperthyroidism

What this trial measures

  • Change in the daily eating windowMeasured weekly from baseline to week 6

    Measured by questionnaire (assesses the time the participant started and stopped eating each day)